Predicting COVID-19 vaccination response in populations who are immunosuppressed

被引：0
作者：
Bechman, Katie [1 ]
Russell, Mark D. [1 ]
Galloway, James B. [1 ]
机构：
[1] Kings Coll London, Ctr Rheumat Dis, London SE5, England
来源：
LANCET RHEUMATOLOGY | 2023年 / 5卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E431 / E432
页数：2
相关论文
共 3 条
  • [1] Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
    Moor, Matthias B.
    Suter-Riniker, Franziska
    Horn, Michael P.
    Aeberli, Daniel
    Amsler, Jennifer
    Moller, Burkhard
    Njue, Linet M.
    Medri, Cesare
    Angelillo-Scherrer, Anne
    Borradori, Luca
    Radonjic-Hoesli, Susanne
    Jafari, S. Morteza Seyed
    Chan, Andrew
    Hoepner, Robert
    Bacher, Vera Ulrike
    Mani, Laila-Yasmin
    Iype, Joseena Mariam
    Hirzel, Cedric
    Maurer, Britta
    Sidler, Daniel
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (11) : E789 - E797
  • [2] Pearce FA, 2023, LANCET RHEUMTOL, V5, P474
  • [3] Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS-CoV-2 vaccination in patients with rheumatic diseases
    Spiera, Robert
    Jinich, Sarah
    Jannat-Khah, Deanna
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (10) : 1357 - +
1